NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Special Investigation of COMIRNATY in the Population With Underlying Diseases

CompletedN/A

Sponsor: Pfizer

Conditions: COVID-19

Interventions: BNT162b2

Countries: Japan

Post-marketing study, Cohort study of COMIRNATY vaccines. To collect information on adverse events and COVID-19 observed after vaccination with COMIRNATY and to assess safety in patients with underlying disease considered to be at high risk of aggravation of COVID-19 who have received vaccination with this product under actual use conditions.

Eligibility overview

Sex: ALL

Age: 12 Years to —

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

-Subjects who are able to understand the content of this study and to record their symptoms in the health observation diary, and who have provided written consent to participate in this survey by themselves (or parents or legal guardians in the case of minors)

Exclusion Criteria:

* There are no exclusion criteria for this study.

Locations (1)

Tokyo, Japan